OXFORD ASSET MANAGEMENT LLP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2020$28,252,000
+14.7%
261,761
+23.7%
3.98%
+482.6%
Q4 2019$24,631,000
+199.6%
211,646
+194.7%
0.68%
+244.9%
Q3 2019$8,221,000
+363.7%
71,815
+220.3%
0.20%
+421.1%
Q4 2017$1,773,000
-0.1%
22,419
+15.4%
0.04%
+11.8%
Q3 2017$1,774,00019,4250.03%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders